ANGELA SAXON: Open Payments
NPI 1710437702 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$715 in 31 payments from 17 companies in 2025. Trend: 2023 $835 · 2024 $593 · 2025 $715
Food & beverage: $715
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 5 | $114 |
| Xeris Pharmaceuticals, Inc. | 1 | $76 |
| Stryker Corporation | 1 | $70 |
| Novo Nordisk Inc | 3 | $60 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| Lilly USA, LLC | 3 | $54 |
| Paratek Pharmaceuticals, Inc. | 2 | $45 |
| Phathom Pharmaceuticals, Inc. | 3 | $36 |
| INTUITIVE SURGICAL, INC. | 1 | $33 |
| Axsome Therapeutics, Inc. | 2 | $31 |
Products named: FREESTYLE LIBRE 3, KEVEYIS, CLOTTRIEVER BOLD CATHETER, Ozempic, MOUNJARO, NUZYRA, FARXIGA, VOQUEZNA.
Industry payments across SC — which companies pay providers there.
